Description
An ATP-competitive inhibitor of the D2 domain of the p97 ATPase (IC50 = 0.11 µM; Ki = 0.22 µM); disrupts ERAD and autophagy pathways; blocks proliferation of HCT15 and SW403 colon cancer cell lines (GI50s = 0.76 and 0.5 µM, respectively), rapidly mobilizing caspase-3 and -7 to induce apoptosis
Formal name: 2-(2-amino-1H-benzimidazol-1-yl)-8-methoxy-N-(phenylmethyl)-4-quinazolinamine
Synonyms:
Molecular weight: 396.4
CAS: 1346527-98-7
Purity: ≥95%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors|ATPases||Research Area|Cancer|Cell Death|Apoptosis||Research Area|Cell Biology|Cell Death|Apoptosis||Research Area|Cell Biology|Cell Signaling||Research Area|Cell Biology|Endomembrane System & Vesicular Trafficking|Autophagy||Research Area|Cell Biology|Proteolysis|Ubiquitin/Proteasome System